Obesity drug maker Novo Nordisk lifts sales forecast – Financial Times

by

  1. Obesity drug maker Novo Nordisk lifts sales forecast  Financial Times
  2. Novo Boosts Profit Outlook on Obesity Drug Demand  Bloomberg Television
  3. Wegovy-maker Novo Nordisk extends curb on supply of weight-loss drug, raises outlook  CNBC
  4. Live news: Novo Nordisk raises guidance as Ozempic and Wegovy sales boom  Financial Times
  5. Wegovy Pushes Novo Nordisk (NVO) Market Value Above Denmark GDP  Bloomberg
  6. View Full Coverage on Google News

Leave a Comment